IMMUNOLOGICAL CONTROL OF AGING - POSSIBLE PRIMARY EVENT

[101] STUTMAN O, 1972, J IMMUNOL, V109, P602

[102] STUTMAN O, 1966, JNCI-J NATL CANCER I, V43, P499

[103] SWANSON CP, 1967, CYTOGENETICS

[104] Taylor R B, 1969, Transplant Rev, V1, P114

[105] TAYLOR RB, 1964, IMMUNOLOGY, V7, P595

[106] TEAGUE PO, 1968, J IMMUNOL, V101, P791

[107] TEAGUE PO, 1970, LAB INVEST, V22, P121

[108] TEAGUE PO, 1965, ARTHRITIS RHEUM, V8, P474

[109] TEAGUE PO, 1969, IMMUNOLOGY, V17, P665

[110] TELLER MN, 1967, JNCI-J NATL CANCER I, V39, P231

[101] STUTMAN O, 1972, J IMMUNOL, V109, P602

[102] STUTMAN O, 1966, JNCI-J NATL CANCER I, V43, P499

[103] SWANSON CP, 1967, CYTOGENETICS

[104] Taylor R B, 1969, Transplant Rev, V1, P114

[105] TAYLOR RB, 1964, IMMUNOLOGY, V7, P595

[106] TEAGUE PO, 1968, J IMMUNOL, V101, P791

[107] TEAGUE PO, 1970, LAB INVEST, V22, P121

[108] TEAGUE PO, 1965, ARTHRITIS RHEUM, V8, P474

[109] TEAGUE PO, 1969, IMMUNOLOGY, V17, P665

[110] TELLER MN, 1967, JNCI-J NATL CANCER I, V39, P231